These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22396166)

  • 41. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of fibroblast growth factor-23 in chronic kidney disease.
    Westerberg PA; Linde T; Wikström B; Ljunggren O; Stridsberg M; Larsson TE
    Nephrol Dial Transplant; 2007 Nov; 22(11):3202-7. PubMed ID: 17567652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial.
    Hanudel MR; Laster ML; Portale AA; Dokras A; Quigley RP; Guzman GAL; Zaritsky JJ; Hayde NA; Kaskel FJ; Mitsnefes MM; Ramirez JA; Imani PD; Srivaths PR; Kogon AJ; Denburg MR; Blydt-Hansen TD; Reyes LZ; Greenbaum LA; Weidemann DK; Warady BA; Elashoff DA; Mendley SR; Isakova T; Salusky IB
    Pediatr Nephrol; 2022 Nov; 37(11):2547-2557. PubMed ID: 35237863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibroblast Growth Factor 23: Mineral Metabolism and Beyond.
    Grabner A; Mazzaferro S; Cianciolo G; Krick S; Capelli I; Rotondi S; Ronco C; La Manna G; Faul C
    Contrib Nephrol; 2017; 190():83-95. PubMed ID: 28535521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal and extrarenal effects of fibroblast growth factor 23.
    Vervloet M
    Nat Rev Nephrol; 2019 Feb; 15(2):109-120. PubMed ID: 30514976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of vitamin D deficiency in chronic kidney disease.
    Gal-Moscovici A; Sprague SM
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V91-4. PubMed ID: 18290730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Klotho/FGF23 Axis in CKD.
    Tsuchiya K; Nagano N; Nitta K
    Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipocalin-2: a novel link between the injured kidney and the bone.
    Courbon G; David V
    Curr Opin Nephrol Hypertens; 2022 Jul; 31(4):312-319. PubMed ID: 35727169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [FGF23 in chronic kidney disease and kidney post-transplant patients].
    Negri A
    Nefrologia; 2009; 29(3):196-202. PubMed ID: 19554051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury.
    Kanbay M; Vervloet M; Cozzolino M; Siriopol D; Covic A; Goldsmith D; Solak Y
    Calcif Tissue Int; 2017 Mar; 100(3):217-228. PubMed ID: 27826644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parathyroid resistance to FGF23 in kidney transplant recipients: back to the past or ahead to the future?
    Komaba H; Koizumi M; Fukagawa M
    Kidney Int; 2010 Nov; 78(10):953-5. PubMed ID: 21030971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FGF23 and Nutritional Metabolism.
    Pool LR; Wolf M
    Annu Rev Nutr; 2017 Aug; 37():247-268. PubMed ID: 28715994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease-A Pediatric Perspective.
    Grund A; Sinha MD; Haffner D; Leifheit-Nestler M
    Front Pediatr; 2021; 9():702719. PubMed ID: 34422725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibroblast growth factor 23 actions in inflammation: a key factor in CKD outcomes.
    Rossaint J; Unruh M; Zarbock A
    Nephrol Dial Transplant; 2017 Sep; 32(9):1448-1453. PubMed ID: 27659127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How FGF23 shapes multiple organs in chronic kidney disease.
    Leifheit-Nestler M; Haffner D
    Mol Cell Pediatr; 2021 Sep; 8(1):12. PubMed ID: 34536161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
    Stöhr R; Schuh A; Heine GH; Brandenburg V
    Front Endocrinol (Lausanne); 2018; 9():351. PubMed ID: 30013515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.
    Scialla JJ
    Curr Opin Nephrol Hypertens; 2015 May; 24(3):260-7. PubMed ID: 26066475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FGF23 and PTH--double agents at the heart of CKD.
    Silver J; Rodriguez M; Slatopolsky E
    Nephrol Dial Transplant; 2012 May; 27(5):1715-20. PubMed ID: 22447519
    [No Abstract]   [Full Text] [Related]  

  • 59. Paracrine Effects of FGF23 on the Heart.
    Leifheit-Nestler M; Haffner D
    Front Endocrinol (Lausanne); 2018; 9():278. PubMed ID: 29892269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.
    Yokota H; Pires A; Raposo JF; Ferreira HG
    Gene Regul Syst Bio; 2010 Jun; 4():53-60. PubMed ID: 20628536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.